<DOC>
	<DOCNO>NCT02139319</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability drug product dose level .</brief_summary>
	<brief_title>Dose-Escalation Botulinum Toxin Subjects With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Osteoarthritis knee Fully weight bear index knee without need assistive/orthopaedic device Pain score â‰¥40 mm index knee Committing continue use assistive/orthopaedic device throughout study use regimen Any infection index knee inflammatory skin disease inflammatory diseases index knee anticipate injection site Surgery symptomatic knee within previous 12 month arthroscopy index knee past 3 month Any painful orthopaedic disorder back hip likely interfere safety efficacy assessments A joint disorder osteoarthritis index knee could potentially interfere safety efficacy assessment</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>